Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hepatitis × Prednisone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 111 Lymphoma 77 Lymphoma, Large B-Cell, Diffuse 72 Precursor Cell Lymphoblastic Leukemia-Lymphoma 30 Burkitt Lymphoma 28 Lymphoma, Follicular 25 Lymphoma, Non-Hodgkin 23 Multiple Myeloma 22 Leukemia 22 Hodgkin Disease 21 Lymphoma, Mantle-Cell 16 Neoplasms 15 Lymphoma, T-Cell, Peripheral 14 Lymphoma, B-Cell 13 Lymphoma, Large-Cell, Immunoblastic 12 Lymphoma, Large-Cell, Anaplastic 10 Dendritic Cell Sarcoma, Interdigitating 9 Lymphoma, B-Cell, Marginal Zone 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Recurrence 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Neoplasm Metastasis 7 Primary Myelofibrosis 6 Neoplasms, Plasma Cell 6 Waldenstrom Macroglobulinemia 5 Graft vs Host Disease 5 Myeloproliferative Disorders 4 Lymphoproliferative Disorders 4 Lymphoma, T-Cell 4 Lymphoma, AIDS-Related 4

Interventions

Ursodeoxycholic Acid 1 Steroids 1 Sofosbuvir 1 Ribavirin 1 Prednisone 1 Mycophenolic Acid 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Adrenal Cortex Hormones 1 3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡